Early insulin treatment in type 2 diabetes: what are the pros?

Journal article

Open access

Peer reviewed

Diabetes care, Vol.32 Suppl 2(11), pp.S266-269

2009-11

PMID: 19875562

Abstract

Hypoglycemic Agents - therapeutic use

Insulin-Secreting Cells - physiology

Prevalence

Glycated Hemoglobin A - metabolism

Humans

Middle Aged

Glycated Hemoglobin A - drug effects

Treatment Outcome

Diabetes Mellitus, Type 2 - epidemiology

Blood Glucose - drug effects

Insulin-Secreting Cells - drug effects

Blood Glucose - metabolism

Diabetes Mellitus, Type 2 - drug therapy

Insulin - therapeutic use

url

https://doi.org/10.2337/dc09-S320View

Published (Version of record) Open

14 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.26 Diabetes; 1.26.42 Diabetes
Web Of Science research areas: Endocrinology & Metabolism
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Early insulin treatment in type 2 diabetes: what are the pros?
Creators: Luigi F Meneghini - Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine, Miami, Florida, USA. lmeneghi@med.miami.edu
Publication Details: Diabetes care, Vol.32 Suppl 2(11), pp.S266-269
Publisher: United States
Academic Unit: Miller School of Medicine
Language: English
Resource Type: Journal article
PMID: 19875562
Record Identifier: 991031561124202976